Dépret, François
Leone, Marc
Duclos, Gary
Futier, Emmanuel
Montagne, Maxime
Legrand, Matthieu
Allaouchiche, Bernard
Clinical trials referenced in this document:
Documents that mention this clinical trial
Monitoring tissue perfusion: a pilot clinical feasibility and safety study of a urethral photoplethysmography-derived perfusion device in high-risk patients
https://doi.org/10.1007/s10877-019-00414-9
Funding for this research was provided by:
Société Française d'anesthésie Réanimation (Contrat de recherche 2018)
Article History
Received: 14 August 2019
Accepted: 25 October 2019
First Online: 6 November 2019
Compliance with ethical standards
:
: FDépret: research grants from the French Ministry of Health and SFAR (société française d’anesthésie réanimation). M Leone: MSD, Pfizer, Octapharma, Aspen, Orion (Lecturer) Aguettant, Amomed (Consultant). Gary Duclos: nothing to declare. Emmanuel Futier: research grants from the French Ministry of Health, consulting fees from Drager Medical, General Electric Healthcare, Edwards Lifesciences, and Orion Pharma, along with lecture fees from Fesenius Kabi, Fisher and Paykel Healthcare, and Getinge. Maxime Montagne: nothing to declare. Matthieu Legrand: research grants from the French Ministry of Health, research support from Sphingotec, lecture fees from Baxter and Fresenius, consulting fees from Novartis. Bernard Allaouchiche: Consulting fees from APD. Consultant for APPD.
: All patients signed an informed consent, and the study was approved by favorable opinion from an ethics committee (CPP Ouest V); the study was registered on the website ExternalRef removed under the identifier NCT03410069 and recorded under the ID-RCB number: 2017-A03466-47.